logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Rocky Mountain Cancer Centers - Aurora

+13038168834
Source: Site record.
https://www.rockymountaincancercenters.com/locations/aurora

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Rocky Mountain Cancer Centers (RMCC) is a leading oncology practice providing comprehensive cancer care across Colorado, with an established clinical research program that gives patients access to clinical trials investigating new cancer treatments and therapies. Its research program covers a broad range of cancers and treatment approaches, allowing patients to participate in studies evaluating innovative therapies while receiving care from oncology specialists.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Cancer treatment center

Business Subcategory

Source: Google. Cancer treatment center
Source: Trial-derived.
392Total Trials
Source: Trial-derived.
56Recruiting Trials
Source: Trial-derived.
213Active Trials
Source: Trial-derived.
136Completed Trials
Source: Trial-derived.
1192Unique Conditions
Source: Trial-derived.
149Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Chronic Lymphocytic Leukemia (15)Source: Trial-derived. Breast Cancer (11)Source: Trial-derived. Invasive Breast Carcinoma (11)Source: Trial-derived. Prostate Cancer (10)Source: Trial-derived. Stage IV Lung Cancer AJCC v8 (10)Source: Trial-derived. Malignant Solid Neoplasm (9)Source: Trial-derived. Breast Carcinoma (8)Source: Trial-derived. Multiple Myeloma (8)

Sponsors

Source: Trial-derived. National Cancer Institute (NCI) (196)Source: Trial-derived. SWOG Cancer Research Network (39)Source: Trial-derived. NRG Oncology (34)Source: Trial-derived. VA Office of Research and Development (31)Source: Trial-derived. Alliance for Clinical Trials in Oncology (30)Source: Trial-derived. ECOG-ACRIN Cancer Research Group (22)Source: Trial-derived. Pfizer (18)Source: Trial-derived. Merck Sharp & Dohme LLC (12)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture
Source: AI-inferred. Telehealth study visits
Source: AI-inferred. Coordination with local labs / imaging
Source: AI-inferred. Remote informed consent

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. CT Scan
Source: AI-inferred. MRI
Source: AI-inferred. SPECT / nuclear medicine
Source: AI-inferred. PET-CT
Source: AI-inferred. Echocardiography
Source: AI-inferred. Mammography
Source: AI-inferred. X-Ray

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Biobanking
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Sequencing / genomics
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Flow Cytometry

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Bone marrow biopsy
Source: AI-inferred. Intensity-modulated radiation therapy
Source: AI-inferred. Apheresis

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Amenities

Amenities Available

Source: Google. Restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. Tumour response imaging (modality not specified)
Source: AI-inferred. CD4 lymphocyte enumeration
Source: AI-inferred. Cystoscopy
Source: AI-inferred. Ophthalmologic examination
Source: AI-inferred. EGFR mutation testing
Source: AI-inferred. Electronic patient-reported outcome (ePRO) system
Source: AI-inferred. Electronic specimen tracking system